SCHEMBL707361

SCHEMBL707361

c1ccc(-c2ncc3[nH]nnc3n2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.47
TDP1 Q9NUW8 3/20 0.47
TP53 P04637 3/20 0.47
L3MBTL1 Q9Y468 7/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
ALOX15 P16050 4/20 0.45
NPC1 O15118 2/20 0.45
ALPL P05186 2/20 0.45
PKM P14618 2/20 0.45
RAB9A P51151 2/20 0.45
HSD17B10 Q99714 2/20 0.45
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.41
TRPM8 Q7Z2W7 2/20 0.41
MEN1 O00255 1/20 0.41
PPP1CA P62136 1/20 0.41
KMT2A Q03164 1/20 0.41
HTT P42858 3/20 0.40
PIM1 P11309 1/20 0.40
METAP1 P53582 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9536716 0.79 HPGDS (0.44) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL4924100 0.76 KDM4E (0.48) KDM4ETDP1TP53L3MBTL1SMN1; SMN2
SCHEMBL27573173 0.74 GAA (0.45) TDP1SMN1; SMN2ALOX15NPC1PKM
SCHEMBL190527 0.74 KDM4E (0.46) KDM4ETDP1TP53L3MBTL1SMN1; SMN2
SCHEMBL21851670 0.73 KDM4E (0.45) KDM4ETDP1TP53L3MBTL1SMN1; SMN2
SCHEMBL13734808 0.71 KDM4E (0.50) KDM4ETDP1TP53L3MBTL1SMN1; SMN2
SCHEMBL17202963 0.71 ADORA3 (0.40) KDM4ETDP1L3MBTL1SMN1; SMN2NPC1
SCHEMBL5470494 0.71 TRPA1 (0.46) MEN1KMT2APOLBHPGD
Dipyridyl SCHEMBL9499580 0.68 KDM4E (0.52) KDM4ETDP1TP53L3MBTL1SMN1; SMN2
SCHEMBL322756 0.67 KDM4E (1.00) KDM4ETDP1TP53L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118113-B1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS ISHIHARA SANGYO KAISHA (JP) 2013-01-30 EP claimed
CN-101611037-B Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process ISHIHARA SANGYO KAISHA 2012-11-28 CN claimed
US-20100087452-A1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS ISHIHARA SANGYO KAISHA, LTD (JP) 2010-04-08 US claimed
CN-101611037-A Pyridyl-triazolopyrimidine derivative or its salt, the sterilant that comprises it and its preparation method ISHIHARA SANGYO KAISHA (JP) 2009-12-23 CN claimed
EP-2118113-A1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS ISHIHARA SANGYO KAISHA, LTD. (JP) 2009-11-18 EP claimed
WO-2008099902-A1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS ISHIHARA SANGYO KAISHA, LTD. (JP) 2008-08-21 WO claimed
CN-107531698-B Fused bicyclic heteroaryl derivatives having activity as PHD inhibitors 武田药品工业株式会社 2024-08-13 CN disclosed
US-10287286-B2 Compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-05-14 US disclosed
US-20180072714-A1 Novel Compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-03-15 US disclosed
EP-3271357-A1 FUSED BICYCLIC HETEROARYL DERIVATIVES HAVING ACTIVITY AS PHD INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2018-01-24 EP disclosed
WO-2016148306-A1 FUSED BICYCLIC HETEROARYL DERIVATIVES HAVING ACTIVITY AS PHD INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-09-22 WO disclosed
EP-2118113-B1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS ISHIHARA SANGYO KAISHA (JP) 2013-01-30 EP disclosed
CN-101611037-B Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process ISHIHARA SANGYO KAISHA 2012-11-28 CN disclosed
CN-101611037-A Pyridyl-triazolopyrimidine derivative or its salt, the sterilant that comprises it and its preparation method ISHIHARA SANGYO KAISHA (JP) 2009-12-23 CN disclosed
CN-101611037-A Pyridyl-triazolopyrimidine derivative or its salt, the sterilant that comprises it and its preparation method ISHIHARA SANGYO KAISHA (JP) 2009-12-23 CN disclosed
EP-2118113-A1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS ISHIHARA SANGYO KAISHA, LTD. (JP) 2009-11-18 EP disclosed
EP-2118113-A1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS ISHIHARA SANGYO KAISHA, LTD. (JP) 2009-11-18 EP disclosed
JP-2008222707-A PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, HARMFUL ORGANISM-CONTROLLING AGENT CONTAINING THE SAME AND METHOD FOR PRODUCING THE SAME ISHIHARA SANGYO KAISHA LTD 2008-09-25 JP disclosed
WO-2008099902-A1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS ISHIHARA SANGYO KAISHA, LTD. (JP) 2008-08-21 WO disclosed
WO-2008099902-A1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS ISHIHARA SANGYO KAISHA, LTD. (JP) 2008-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072714-A1 Novel Compounds F12, HAX1, C1S KDM4E 3403/4885TDP1 3457/4885TP53 2990/4885
US-10287286-B2 Compounds F12, C1S, F3 KDM4E 2878/4885TDP1 3453/4885TP53 2183/4885
US-20100087452-A1 PYRIDYL-TRIAZOLOPYRIMIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND ITS PRODUCTION PROCESS SCN5A, CHRNA5, NR5A2 KDM4E 1717/4885TDP1 2447/4885TP53 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.